Short-term Blinatumomab as a Bridge Therapy for Allo-HSCT in Low Burden B-ALL
Clinical trial NCT06111625 · RECRUITING
Trial details
- NCT number
- NCT06111625
- Sponsor
- Sichuan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-10
- Primary completion
- 2024-08-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.